Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-04-08 Purchase |
2024-04-10 5:16 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
8,308 | $1.2313 | $10,229 | 1,005,007 (Indirect Direct) |
View |
2023-08-31 Purchase |
2023-08-31 1:54 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
4,954 | $2.22 | $10,998 | 619,160 (Indirect Direct) |
View |
2023-03-31 Purchase |
2023-04-04 07:00 am |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
747 | $3.56 | $2,659 | 614,206 (Indirect Direct) |
View |
2022-11-21 Purchase |
2022-11-21 5:14 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
943 | $2.6162 | $2,467 | 513,801 (Indirect Direct) |
View |
2022-10-12 Purchase |
2022-10-12 2:01 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
725 | $3.3884 | $2,457 | 512,858 (Indirect Direct) |
View |
2022-10-11 Purchase |
2022-10-12 08:54 am |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
806 | $3.6886 | $2,973 | 512,133 (Indirect Direct) |
View |
2022-08-26 Purchase |
2022-09-09 6:17 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
5,723 | $3.2809 | $18,777 | 511,327 (Indirect Direct) |
View |
2022-08-26 Sale |
2022-09-09 6:17 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
3,958 | $3.388 | $13,410 | 511,327 (Indirect Direct) |
View |
2021-11-19 Purchase |
2021-11-22 12:17 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
4,000 | $6.6565 | $26,626 | 496,299 (Indirect Direct) |
View |
2021-11-16 Purchase |
2021-11-16 5:23 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
7,826 | $6.7252 | $52,632 | 492,299 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-14 Option Award |
2025-02-19 4:25 pm |
N/A 2035-02-14 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
768,979 | $0 | 1,773,977 (Direct) |
View |
2024-03-18 Tax Withholding |
2024-03-20 4:38 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
17,193 | $1.39 | 996,699 (Direct) |
View |
2024-02-13 Option Award |
2024-02-15 4:13 pm |
N/A 2034-02-13 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
394,737 | $0 | 1,013,896 (Direct) |
View |
2023-03-20 Tax Withholding |
2023-03-22 4:49 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
6,729 | $2.92 | 613,459 (Direct) |
View |
2023-02-18 Tax Withholding |
2023-02-28 07:26 am |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
374 | $2.99 | 620,188 (Direct) |
View |
2023-02-17 Option Award |
2023-02-17 5:29 pm |
N/A 2033-02-17 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
106,762 | $0 | 620,562 (Direct) |
View |
2022-11-03 Option Award |
2022-11-04 4:27 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
335,538 | $0 | 512,858 (Direct) |
View |
2022-06-14 Option Award |
2022-06-15 2:55 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
263 | $3.7774 | 509,563 (Direct) |
View |
2022-06-07 Option Award |
2022-06-08 09:37 am |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
565 | $4.6493 | 509,300 (Direct) |
View |
2022-03-18 Option Award |
2022-03-22 5:11 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
12,438 | $0 | 508,736 (Direct) |
View |
2021-11-04 Option Award |
2021-11-08 5:35 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
335,538 | $0 | 484,474 (Direct) |
View |
2021-03-18 Option Award |
2021-03-19 5:05 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
1,760,876,961 | $0 | 1,769,661,356 (Direct) |
View |
2020-11-23 Other |
2020-11-24 4:02 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
8,375,671 | $0 | 17,160,066 (Direct) |
View |